Treatment of lung cancer cell lines with pioglitazone – an agonist of the nuclear receptor peroxisome proliferator activated receptor gamma – decreased the proliferation rates via increased FAO; which activated the tumour suppressor protein retinoblastoma to effect cell cycle arrest. This evidence concerns the gene PPARG and lung cancer.